Beam Therapeutics BEAM Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's other income (expense)?
- Beam Therapeutics (BEAM) reported other income (expense) of $12.9M in Q1 2026.
- How has Beam Therapeutics's other income (expense) changed year-over-year?
- Beam Therapeutics's other income (expense) increased by 17.7% year-over-year, from $10.96M to $12.9M.
- What is the long-term trend for Beam Therapeutics's other income (expense)?
- Over 4 years (2021 to 2025), Beam Therapeutics's other income (expense) has grown at a 90.7% compound annual growth rate (CAGR), from $23.05M to $304.64M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.